Kemwell Biopharma

There are various challenges and opportunities which are faced by scientists during the development of oral formulation. The dose requirements in the development help the manufacturers to explore opportunities and formulations to better solubilization. There are a lot of factors which are included in the development are organic and aqueous solubility, stability, polymers, compatibility, surfactants, types of solubilizers and lot more. The development of safe oral formulation needs liquid dispersions instead of the solid ones. In order to get a particular dosage with high quality, efficacy, and safety, people use the best quality of oral formulation.   Challenges in Oral formation development Whenever a kind of drug is manufactured, then there are a number of challenges faced by the companies and the same happens during the oral Formulation Development procedure. The aging population will be looking for medications which can treat diseases caused at later stages of ...

As you know, contract manufacturing is getting popular all over the world, especially in the Pharmaceutical and Biotech industries. Contract manufacturing is considered as the process of outsourcing for the manufacturing of all the products of any Pharmaceutical organisation. There are lots of companies available to offer these contract manufacturing solutions for the pharmaceutical industry. With the services of these companies, any pharmaceutical organisation can reduce the manufacturing cost and can find the assurance of quality in the products with Outsourcing and contract manufacturing professionals . According to the reports, the need of contract manufacturing is growing in the global pharmaceutical industry and it will grow at CAGR of about 7% by the year 2020. Here comes the question that why pharmaceutical industry use depending on contract manufacturing and why the trend of contract manufacturing is getting popular in the Global Pharmaceutical sector.  F...

Over the last two decades, the collaboration between contract manufacturing organisations and pharmaceutical companies has become prominent and the contract manufacturing companies are playing a big role in the development and production process for the pharmaceutical industries. It is true that the smaller pharma companies are getting help at a bigger level with contract manufacturing organisations as compared to the leading companies in the market. For the smaller companies, about 80% of the manufacturing process is completed by CMOs at the present time. According to the reports, two third of the manufacturing process is completed with the help of CMOs for many life science companies. It is true that contract manufacturing companies are looking to expand the role in pharmaceutical manufacturing projects and they are expanding the services for the clients in the market. Today, Medical and pharmaceutical companies rely on a big level on CMOs and these companies are avail...

Due to a significant increase in the number of diseases across the world, it becomes the responsibility of the drug manufacturing companies to pay more attention to the efficiency of medicines. Special software and tools should be used to improve the condition of present medicines. Most of the Biopharmaceutical companies are investing in Real World Evidence in order to improve the drug outcomes. Why Pharmaceutical companies have started investing in Real World Evidence? To get a significant insight into the performance of drugs, real-world evidence is beneficial for the companies. Health outcomes of the patients can be improved with the help of real-world data sources and EMR as it results in inefficient drug development with better commercialization. It becomes possible to develop better therapies quicker which are helpful to the biopharmaceutical industries and patients also. Biopharmaceutical Contract Manufacturing companies have started taking help of RWE becaus...

Monoclonal antibodies contract manufacturing, Due to a heightened increase in collaboration between CMOs and pharmaceutical industries, there is a growth seen in the capacity investments. This is necessary for the contract manufacturing companies in order to meet all the necessary requirements of the pharmaceutical industries . Monoclonal antibodies are ruling the biopharmaceutical market and companies struggle while securing the manufacturing capacity of the company in such a time. For every biopharmaceutical company, it is important to pay attention to clinical capacity along with the commercial business. Why there is a sudden increase in Monoclonal antibodies production? Due to an increase in infectious diseases all over the world, the need to monoclonal antibodies is increasing every day.  These are the glycoproteins which are identical to the immune cells of the human body and it can assume that they are clones of the parent cell. As the need for these medicines ...